Phase 4 N=61 Preoperative Pain Control in Gastric Bypass Surgery Patients
Post-operative Pain
Primary: Post-operative Pain Medication Requirements — 13.76; 17.32; 40.89; 46.63 MME — p=0.10
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=34 Perioperative Ketamine for Pain With Gastric Bypass
Laparoscopic Gastric Bypass Surgery · Ketamine
Primary: Total Cumulative Perioperative Opioid Dose — 179.9; 248.6 Morphine Equivalents — p=0.03
Phase 3 N=120 The Use of Intraperitoneal Ropivacaine in Bariatric Bypass Surgery
Bariatric Surgery Candidate
Primary: 0-1 h Postoperative Pain Level — 3.9762; 4.3149 units on a scale
Phase 3 N=96 Patients-Controlled Epidural Analgesia After Gastric Bypass for Morbid Obesity Using Morphine-Levobupivacaine Regimens
Morbid Obesity · Postoperative Pain · Postoperative Bowel Function
Primary: Change From Baseline in Pain Scores (Visual Analogue Scale) — 1.4; 1.6; 1.6; 0.8 units on a scale
Phase 4 N=102 Efficacy of Exparel (TM) on Post-operative Pain After Laparoscopic Gastric Bypass Using Circular EEA Stapler
Post-operative Pain Management
Primary: Post-Operative Pain — 49.4; 56.6 units on a Visual Analog Scale (VAS)
N/A N=19 The Effect of Pre-Operative Transversus Abdominis Plane (TAP) Block in the Post Operative Opioid Consumption in Morbid Obese Patients Undergoing Laparoscopic Gastric Bypass Surgery: A Prospective,Randomized, Blinded Study
Pain · Obesity · Surgery
Primary: Quality of Recovery 40 Score — 170; 175.5 units on scale 40 (low) - 200 (high) — p=.05
Phase 3 N=90 Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy
Pain · Postoperative Depression
Primary: Change in Pain Scores — 1.45; 1 score on a scale
Phase 4 N=126 Bupivacaine Liposomal Injection (Exparel) for Postsurgical Analgesia in Patient Undergoing Laparoscopic Bariatric Surgery
Pain, Postoperative
Primary: Total Amount of Opioids at 48 Hours — 29.5; 27.1 mg
Phase 3 N=20 Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients
Bariatric Surgical Pain
Primary: Postoperative Pain — 3; 4.5; 8; 8 units on a scale
N/A N=62 Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting
Obesity, Morbid · Postoperative Pain · Postoperative Nausea and Vomiting
Primary: Evaluate the Amount of Diluadid Given Postoperatively — 11.035; 8.7; 12.4 ml
N/A N=53 Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass
Gastroesophageal Reflux Disease · Morbid Obesity
Primary: Number of Participants Presenting Reflux Symptoms — 31; 8; 5 participants — p=<0.001
N/A N=34 Food Preference Following Bariatric Surgery
Obesity
Primary: Total Food Intake (Lunch Buffet) at 24 Months — 2540.1; 721 kJ
Phase 2 N=23 Regional TAP Block for Bariatric Patients
Bariatric Surgery · Transverse Abdominal Plane Regional Blocks
Primary: Post Operative Opioid Usage — 2.25; 4 morphine equivalent
N/A N=96 Postoperative Opioid Consumption in Gastric Sleeve Surgery
Obesity &Amp; Overweight · General Anesthetic · Ketamine
Primary: Morphine Equivalent Opioid Consumption — 40; 30 miligram
N/A N=55 Effects of Gastric Bypass Surgery and Calcium Metabolism and the Skeleton
Obesity, Morbid · Gastric Bypass
Primary: Change in Intestinal Calcium Absorption — -25.8 % of ingested calcium that is absorbed
N/A N=197 Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
Morbid Obesity
Primary: Excess Weight Loss From Pre-operation to 5 Years Post-operation — 68.4; 45.4 percent change
N/A N=51 IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery
Pain · Obesity
Primary: Quality of Recovery 40 on the Day After Surgery — 165; 146 units on scale 40 (low) - 200 (high) — p=.01
N/A N=22 Diabetes and Gastric By- Pass
Type 2 Diabetes
Primary: Response in Glucose AUC at Baseline vs. Following Gastric Bypass Surgery — 61647.0; 59476.1 mg/dL*min
N/A N=25,038 Risk Factors Predicting Serious Complications With Laparoscopic Gastric Bypass Surgery
Postoperative Complications
Primary: Serious Complications — 630 Participants
N/A N=100 Perioperative Pain Management In Spine Surgery Patients: Part I
Pain
Primary: Immediate Postoperative Pain Control — 6.6; 6.8 score on a scale
Phase 3 N=68 Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy
Pain, Postoperative
Primary: Total Opioid Pain Medications Required 0-3h Post op in Morphine Milligram Equivalents (MME) — 2.00; 5.32 morphine milligram equivalents (MME)
Phase 4 N=30 Intraperitoneal Bupivicaine Infusion Using the On-Q Pain Pump After Laparoscopic Surgery
Postoperative Pain
Primary: Visual Aanalog Scale (VAS) for Pain Assessment With Cough at 48 Hours — 1.7; 3.9 units on a scale — p=.0022
Phase 3 N=26 Dexmedetomidine to Treat Bariatric Surgery-associated Pain
Obesity
Primary: Pain Scores (Numerical Rating Scale 0-10) Using the Faces Pain Scale-Revised — 5; 3.4 Units on a scale
N/A N=150 Gastric Procedures for Obesity
Morbid Obesity
Primary: Change in Body Weight — -21.4; -36.6; -7.0 kg
Phase 4 N=80 Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study
Pain · Obesity · Hypoxia
Primary: Quality of Recovery 40 — 170; 179 score on a scale
N/A N=41 The Effects of Glycemic Optimization Before Gastric Bypass Surgery
Type 2 Diabetes
Primary: Composite of Fasting Glucose, Glycosylated Haemoglobin c and Rates of Type 2 Diabetes Mellitus Remission. — 6; 6 Participants
Phase 4 N=11 The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass Surgery
Hypoglycemia
Primary: Difference Score: Percent of Time Spent in Hypoglycemic State — 1.2 Difference score, trt-control (percent) — p=0.99
Phase 4 N=43 Unilateral TAP Block for Laparoscopic Gastric Sleeve Surgery
Laparoscopic Sleeve Gastrectomy · Subcostal Transversus Abdominis Plane Block
Primary: Amount of 24 Hour Opioid Consumption — 44.7; 38.7 morphine milligram equivalents
N/A N=86 Pregabalin for the Treatment of Pain After Posterior Spinal Fusions
Lumbar Spinal Fusions
Primary: Patient Controlled Analgesia (PCA) Hydromorphone Usage — 44; 39 mL
Phase 3 N=20 Effects of Gastric Bypass on Blood Levels of Duloxetine
Bariatric Surgery
Primary: Cmax — 51.04; 61.41 ng/ml